<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <!-- Responsive -->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0">

    <title>OtiTopic</title>

    <!-- Favicon -->
    <link rel="shortcut icon" type="image/x-icon" href="img/favicon.png" />

    <!-- Google Font -->
    <link href="https://fonts.googleapis.com/css?family=Nunito:300,400,600,700&display=swap" rel="stylesheet">

    <!-- css styles -->
    <link rel="stylesheet" href="css/owl.carousel.min.css" />
    <link rel="stylesheet" href="css/owl.theme.default.min.css" />
    <link rel="stylesheet" href="css/icofont.min.css" />
    <link rel="stylesheet" href="css/bootstrap.min.css" />
    <link rel="stylesheet" href="css/style.css" />

    <!-- Cookies Notification -->
    <link rel="stylesheet" type="text/css" href="//wpcc.io/lib/1.0.2/cookieconsent.min.css"/>
    <script src="//wpcc.io/lib/1.0.2/cookieconsent.min.js"></script>
    <script>window.addEventListener("load", function(){window.wpcc.init({"border":"thin","corners":"small","colors":{"popup":{"background":"#f6f6f6","text":"#000000","border":"#555555"},"button":{"background":"#555555","text":"#ffffff"}},"position":"bottom","content":{"href":"https://synthesisgroup.github.io/otitopic/privacy-policy.html"}})});</script>

    <!-- 1. Add latest jQuery and fancybox files -->
    <script src="https://cdn.jsdelivr.net/npm/jquery@3.4.1/dist/jquery.min.js"></script>
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/fancyapps/fancybox@3.5.7/dist/jquery.fancybox.min.css" />
    <script src="https://cdn.jsdelivr.net/gh/fancyapps/fancybox@3.5.7/dist/jquery.fancybox.min.js"></script>

</head>

<body id="no-scroll">

    <!-- Start Pre-loader -->
    <div class="pre-loader-wrap">
        <div class="pre-loader">
            <img src="img/icons/preloader.svg" alt="icon">
            <span>Loading...</span>
        </div>
    </div>
    <!-- End Pre-loader -->

    <!-- Start header section -->
    <section class="header-section research-banner">
        <header class="header-area">
            <div class="dope-nav-container breakpoint-off">
                <div class="container">
                    <div class="row">
                        <!-- Main Menu -->
                        <nav class="dope-navbar justify-content-between" id="dopeNav">

                            <!-- Logo -->
                            <a class="nav-brand" href="index.html"><img src="img/otitopic-logo-header.svg" alt="" width="100"></a>

                            <!-- Navbar Toggler -->
                            <div class="dope-navbar-toggler">
                                <span class="navbarToggler"><span></span><span></span><span></span></span>
                            </div>

                            <!-- Menu -->
                            <div class="dope-menu">
                                <!-- aside logo -->
                                <a class="nav-brand-side" href="index.html"><img src="img/otitopic-logo-header.svg" alt="" width="100"></a>
                           
                                <!-- close btn -->
                                <div class="dopecloseIcon">
                                    <div class="cross-wrap"><span class="top"></span><span class="bottom"></span></div>
                                </div>

                                <!-- Nav Start -->
                                <div class="dopenav">
                                    <ul id="nav">
                                        <li><a href="index.html">Home</a></li>
                                        <li><a href="about-us.html">About Us</a></li>
                                        <li><a href="therapies.html">Therapies</a></li>
                                        <li><a href="research.html" class="active">Research</a></li>
                                        <li><a href="technology.html">Technology</a></li>
                                        <li><a href="investors.html">Investors</a></li>
                                        <li><a href="press-releases.html">Press Releases</a></li>
                                        <li><a href="contact-us.html">Contact Us</a></li>
                                    </ul>

                                    <!-- <div class="footer-widgets-aside">
                                        <ul class="social-lists">
                                            <li><a href="#" target="__blank"><img src="img/icons/fb.svg"></a></li>
                                            <li><a href="#" target="__blank"><img src="img/icons/in.svg"></a></li>
                                            <li><a href="#" target="__blank"><img src="img/icons/tw.svg"></a></li>
                                            <li><a href="#" target="__blank"><img src="img/icons/yt.svg"></a></li>
                                        </ul>
                                    </div> -->
                                </div>
                                <!-- Nav End -->
                            </div>
                        </nav>

                        <!-- Start Nav Overlay -->
                        <div class="overlay"></div>
                        <!-- End Nav Overlay -->

                    </div>
                </div>
            </div>
        </header>

    </section>
    <!-- End header section -->

    <!-- Start Main Page Wrapper -->
    <main>

        <!-- Start Header Banner -->
        <section class="otitopic-header-info">
            <div class="container">
                <div class="row">
                    <div class="col-lg-6 col-xl-6">
                         <div class="banner-tag-head">
                            <h2>Research</h2>
                            <ul>
                                <li>We are a late-stage drug development company with a track record of success in pharmaceutical product development.</li>
                            </ul>
                        </div>
                    </div>
                    <div class="col-lg-5 col-xl-11">
                        <ul class="breadcrumbs">
                          <li><a href="index.html" class="inactive">Home</a></li>
                          <li><a href="#" class="active">Research</a></li>
                        </ul>
                    </div>
                </div>
            </div>
        </section>
        <!-- End Header Banner -->

        <!-- Start myocardial infarction section -->
        <section class="myocardial-infarction-section section-gap clear-fix custom-height-myocardial">
            <div class="container">
                <div class="justify-content-between col-md-myocardial">
                    <div class="img-wrap">
                        <img src="img/iStock-956478224.jpg" alt="img">
                    </div>
                    <div class="text-wrap-myocardial">
                        <h2>A New Era in Myocardial Infarction Management</h2>

                        <p class="mt-3">In 2019, OtiTopic completed a dose range study. Asprihale® reaches peak plasma concentration in two
                        minutes versus 20 minutes for 162 mg non-enteric coated chewable aspirin. This rapid exposure is
                        unprecedented and has enormous implications for early disruption of an evolving thrombus, where
                        differences in time of restoration of blood flow within minutes with different therapies can be life-altering. The very high levels of serum thromboxane B2 (TxB2 ) suppression, and complete inhibition of
                        arachidonic acid (AA)-induced platelet aggregation, both within two minutes, are unprecedented for a
                        non-parenterally administered antiplatelet therapy.</p>
                    </div>
                </div>
            </div>
       
            <div class="info-section">
                <div class="container">
                    <div class="row d-flex align-items-center">
                        <div class="col-lg-12 col-md-12 info-left">
                            <div class="info-left-wrap">
                                <ul class="grid-container-flex-two">
                                    <li>
                                        <div class="list-number"><img src="img/icons/check.svg" alt="icon"></div>
                                        <div class="details">
                                            <p>Asprihale® aspirin exposure occurred more rapidly compared to chewed aspirin</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/check.svg" alt="icon"></div>
                                        <div class="details">
                                            <p>With respect to Asprihale® PK, there is a 1.6-fold greater Cmax of aspirin when inhaled, which is similar to IV administration</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/check.svg" alt="icon"></div>
                                        <div class="details">
                                            <p>Asprihale® early and consistent reduction in TxB2 led to early and consistent suppression of platelet aggregation by AA in two minutes</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/check.svg" alt="icon"></div>
                                        <div class="details">
                                            <p>The immediate antiplatelet and inhibitory effects of Asprihale® would be expected to translate to meaningful clinical benefits in the early evolution of arterial thrombosis</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/check.svg" alt="icon"></div>
                                        <div class="details">
                                            <p>Decreased interpatient variability of TxB2 inhibition and AA-induced platelet aggregation when aspirin is administered by the inhaled route of administration</p>
                                        </div>
                                    </li>
                                    <li>
                                        <div class="list-number"><img src="img/icons/check.svg" alt="icon"></div>
                                        <div class="details">
                                            <p>The individual data for both AA-induced platelet aggregation and TxB2 inhibition show more rapid and consistent response in two minutes than chewable aspirin</p>
                                        </div>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
       
            <div class="otitopic-research-tech-trials-section mt-4">
                <div class="container">
                
                    <div class="justify-content-between align-items-center col-md-rev-otitopic-research">
                        <div class="text-wrap">
                            <h2>OtiTopic Research</h2>
                            
                            <div class="col-grid-text">
                                <p>OtiTopic's proprietary formulation contains particles engineered to produce an aerodynamic profile that results in maximum deep lung delivery. The aerodynamic profile is a result of the interaction between the inhaler and the formulation’s properties such as particle size and density. OtiTopic has evaluated countless formulations and devices to ensure that patients will receive an optimal therapy for management of suspected acute MI.</p>
                                
                                <p>The current formulation has undergone design of experiment studies to prepare for validation of the commercial manufacturing process. Most analytical methods have passed Phase III validation to support sale and marketing of Asprihale® in the US. OtiTopic has been issued multiple patents and is the only company that can market orally inhaled dry powder aspirin worldwide.</p>
                            </div>
                        </div>
                    </div>

                    <div class="justify-content-between align-items-center col-md-rev">
                        <div class="text-wrap">
                            <h2>Technology</h2>
                            <br>
                            <p>The interaction between our capsule-based DPI and proprietary formulation creates an ideal aerodynamic profile that allows for deep lung delivery of the active ingredient. Asprihale® is easy to use and is delivered into the bloodstream in less than two minutes.</p>
                            <a href="technology.html" class="theme-btn btn-style-secondary mt-3"><span class="txt">Learn more</span></a> 
                        </div>
    
                        <img src="img/technology-thumbnail.jpg" class="img-wrap">
                    </div>

                    <div class="justify-content-between align-items-center col-md-rev-trials section-gap-top">
                        <!-- <img src="img/ecg-thumbnail.JPG" class="img-wrap"> -->
                        <video width="100%" autoplay="autoplay" muted="muted" loop="loop"> 
                            <source src="img/videos/otitopic-ecg-video.mp4" type="video/mp4">
                        </video>
                        <div class="text-wrap-trials">
                            <h2>Clinical Trials</h2>
                            <p class="mt-4">Asprihale® is a 505(b)(2) project. FDA has agreed that an accelerated clinical plan would be sufficient to bring the drug to market. OtiTopic has completed a dose range study and is preparing for a randomized pivotal PK/PD study to establish bioequivalence.</p>

                            <p>Clinical data indicates A 1.5 fold greater maximum serum concentration (Cmax) of acetylsalicylic acid (ASA) is achieved within 2 minutes.</p>

                            <p>When delivered with ASPRIHALE Arachidonic acid induced platelet aggregation is completely and irreversibly inhibited with ASPRIHALE within ~2 minutes post dose, and maintained for 24 hours post treatment.
                            </p>

                        </div>
                    </div>

                    <div class="row justify-content-center align-items-center">
                        <div class="col-md-5">
                            <a data-fancybox="gallery" href="img/graph-1.png">
                                <img src="img/graph-1.png" width="100%" class="mt-50">
                            </a>
                        </div>
                        <div class="col-md-5">
                            <a data-fancybox="gallery" href="img/graph-2.png">
                                <img src="img/graph-2.png" width="100%" class="mt-50">
                            </a>
                        </div>
                    </div>

                    <div class="justify-content-between align-items-center col-md-rev-trials section-gap-top">

                        <div class="card-wrap">
                            <p>Asprihale® completely inhibits AA-induced platelet aggregation within two minutes versus 30 minutes for chewable aspirin.</p>
                        </div>

                        <div class="card-wrap">
                            <p>Inhibition of TxB2 in the first 20 minutes was greater in the Asprihale® group.</p>
                        </div>
                        
                        <div class="card-wrap">
                            <p>Mean serum thromboxane B2 (TxB2) levels are dramatically reduced over the first ~2 minutes post dose with ASPRIHALE, and maintained for 24 hours post treatment
                            </p>
                        </div>

                        <div class="card-wrap">
                            <p>The immediate anti platelet and inhibitory effects of ASPRIHALE is expected to translate to meaningful clinical benefits for patients at risk for MI</p>
                        </div>

                    </div>
                </div>
            </div>
        </section>
        <!-- End therapies section -->

        <!-- Start testimonials section -->
        <section class="testimonials-section section-gap-bottom clear-fix section-mobile-gutter">
            <div class="container">
                <div class="row justify-content-center d-flex">
                    <div class="col-lg-10 gallery-wrap">
                        <div class="outer">
                            <div id="big" class="owl-carousel owl-theme portfolio-carousel">

                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>This product would be especially useful for patients having a STEMI. The problem is that the patient has no way of knowing whether their symptoms indicate a STEMI or N-STEMI. If they are truly in an emergent STEMI situation, every second counts and the faster you can inhibit platelet aggregation, the less damage is done to the cardiac muscle.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>KOL</h4>
                                            <p>University of Pittsburgh Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>

                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I am not perfectly systematic when it comes to recommending rescue aspirin to my patients. When aspirin comes up in conversation, I will mention that a rescue aspirin is a good idea in the event of a heart attack. Since the guideline update my patients and I have been discussing aspirin more often.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Cardiologist KOL</h4>
                                            <p>Harbor-UCLA Medical Center</p>
                                        </div>
                                    </div>

                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I think this product is great. In the ER we often see acute MI patients that have not received aspirin from EMS. If they had this product with them, my patients would be a lot safer.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>ER Physician</h4>
                                            <p>Mount Sinai</p>
                                        </div>
                                    </div>
                                    
                                </div>

                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I am most worried about my highest risk patients, those that have already had a heart attack. These are the patients that I would prescribe Asprihale® because the benefits outweigh the costs.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Cardiologist</h4>
                                            <p>NYU Langone</p>
                                        </div>
                                    </div>
                                    
                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I would definitely give this product to all my high risk patients. I think it could benefit anyone at high risk of a heart attack where every second counts. Aspirin is the only rescue therapy that we have for an acute MI, so this is an important product to provide to my at risk patients.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>PCP</h4>
                                            <p>One Medical</p>
                                        </div>
                                    </div>
                                    
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End testimonials section -->
      
        <!-- Start call to action section -->
        <section class="cta-section section-gap-top section-gap-bottom clear-fix">
            <div class="container">
                <div class="row d-flex align-items-center col-md-rev">
                    <div class="col-lg-9 col-md-12">
                        <img src="img/icons/mail.svg" alt="mail-icon">
                        <h2>Get in touch with us for more info about OtiTopic, Inc.</h2>
                        <div class="btn-flex mt-40">
                            <a href="contact-us.html" class="theme-btn btn-style-secondary"><span class="txt">Get in touch</span></a>  
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End call to action section -->

    </main>
    <!-- End Main Page Wrapper -->

  
    <!-- Start footer section -->
    <footer class="footer-section section-gap-top clear-fix">
        <div class="container">
            <div class="grid-row-footer footer-top section-gap-bottom">

                <div class="grid-footer-1">

                    <div class="footer-widgets">
                        <img class="footer-logo" src="img/Otitopic-logo-(Apr-2020)-RGB-144dpi.png" width="100px" alt="logo-footer">
                        <p class="footer-brand-excerpt">OtiTopic, Inc. is a late-stage pharmaceutical company, with a track record of success in product drug delivery and drug device development.</p>
                        <!-- <ul class="social-lists">
                            <li><a href="#" target="__blank"><img src="img/icons/fb.svg"></a></li>
                            <li><a href="#" target="__blank"><img src="img/icons/in.svg"></a></li>
                            <li><a href="#" target="__blank"><img src="img/icons/tw.svg"></a></li>
                            <li><a href="#" target="__blank"><img src="img/icons/yt.svg"></a></li>
                        </ul> -->
                    </div>

                </div>

                <div class="grid-footer-2">

                    <div class="footer-widgets">
                        <div class="single-widget">
                            <h4 class="wiget-title">Company</h4>
                            <ul class="list-style">
                                <li><a href="about-us.html">About us</a></li>
                                <li><a href="contact-us.html">Contact Us</a></li>
                                <li><a href="privacy-policy.html">Privacy Policy</a></li>
                            </ul>
                        </div>
                    </div>

                    <div class="footer-widgets">
                        <div class="single-widget">
                            <h4 class="wiget-title">Our Science</h4>
                            <ul class="list-style">
                                <li><a href="therapies.html">Therapies</a></li>
                                <li><a href="research.html">Research</a></li>
                                <li><a href="technology.html">Technology</a></li>
                            </ul>
                        </div>
                    </div>

                    <div class="footer-widgets">
                        <div class="single-widget">
                            <h4 class="wiget-title">Investors</h4>
                            <ul class="list-style">
                                <li><a href="investors.html">Investor Relations</a></li>
                                <li><a href="press-releases.html">Press Releases</a></li>
                            </ul>
                        </div>
                    </div>

                </div>

            </div>

            <div class="copyright-bottom d-flex">
                <div class="text-left">
                    <p>&copy; Copyright OtiTopic <span id="year"></span>. All Rights Reserved.</p>
                </div>
            </div>
        </div>
    </footer>
    <!-- End footer section -->

    <!-- Start Scroll Top -->
    <div class="scroll-top">
        <i class="icofont-rounded-up"></i>
    </div>
    <!-- End Scroll Top -->

    <!-- JS Files -->
    <script src="js/jquery-3.3.1.slim.min.js"></script>
    <script src="js/popper.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
    <script src="js/owl.carousel.min.js"></script>
    <script src="js/dopeNav.js"></script>
    <script src="js/odometer.js"></script>
    <script src="js/tilt.jquery.min.js"></script>
    <script src="js/main.js"></script>
    <script>document.getElementById("year").innerHTML = new Date().getFullYear();</script>
</body>

</html>